The thioredoxin-1 system fuels DNA biosynthesis during lymphocyte metabolic reprogramming

The thioredoxin-1 and the glutathione/glutaredoxin-1 systems are key players in preserving cytosolic redox balance. How these redox systems serve cellular and humoral immunity mediated by T cells and B cells, respectively, remains unknown. Two recent publications by the Kopf group (IMHS) revealed the underlying mechanism.  

Thioredoxin

Lymphocyte activation leads to a switch from oxidative phosphorylation to aerobic glycolysis to satisfy the increased metabolic demands of proliferating cells. Investigations by Jonathan Muri et al now revealed that T cells exploit the thioredoxin-1 (Trx1) pathway to provide reducing power for the synthesis of DNA building blocks by ribonucleotide reductase at the last step of the pentose phosphate pathway. Interestingly, while T cells are absolutely dependent on the Trx1 system for efficient expansion, B cells with a defective thioredoxin system can rearrange their redox system and utilize the glutathione/glutaredoxin-1 pathway as a backup for development and immune responses. These findings may have profound implications for therapies of B and T cell neoplasms.

Link to the publication in external page Nature Communications"

Link to the publication in external page European Journal of Immunology

 

Comments

Leave a comment

Leave a comment

We are happy if you comment on articles on ETH channels, ask questions or respond to comments from other readers. Please note our comment policy when doing so.

No comments yet